Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Kenter

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 1, 1997
The relevance of various vulvar epithelial changes in the early detection of squamous cell carcinoma of the vulvaM J Kagie, G G Kenter, J Hermans, et al.
Anticancer Research|July 1, 1997
Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancerK N Gaarenstroom, J M Bonfrer, C M Korse, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 15, 1992
[Morbidity and results of 100 radical hysterectomies performed in an oncology center]J B Trimbos, B Adema, A A Peters, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2001
A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patientsJ B Trimbos, C P Maas, M C Deruiter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 19, 2007
An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate modelQ D Pieterse, G G Kenter, P H C Eilers, et al.
BMC Cancer|September 14, 2018
'DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironmentJ Rotman, C H Mom, E S Jordanova, et al.
Gynecologic Oncology|October 19, 2001
Cytokine profile of cervical cancer cellsS Hazelbag, G J Fleuren, J J Baelde, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 8, 1990
[Lessons from gynecological-pathological discussions]J B Trimbos, A A Peters, G G Kenter, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 25, 2000
The long learning curve of gynaecological cancer surgery: an argument for centralisationJ B Trimbos, B W Hellebrekers, G G Kenter, et al.
Hematology/Oncology Clinics of North America|March 18, 1999
Immunotherapeutic strategies for cervical squamous carcinomaW J van Driel, G G Kenter, G J Fleuren, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 1, 1997
The relevance of various vulvar epithelial changes in the early detection of squamous cell carcinoma of the vulvaM J Kagie, G G Kenter, J Hermans, et al.
Anticancer Research|July 1, 1997
Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancerK N Gaarenstroom, J M Bonfrer, C M Korse, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 15, 1992
[Morbidity and results of 100 radical hysterectomies performed in an oncology center]J B Trimbos, B Adema, A A Peters, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2001
A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patientsJ B Trimbos, C P Maas, M C Deruiter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 19, 2007
An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate modelQ D Pieterse, G G Kenter, P H C Eilers, et al.
BMC Cancer|September 14, 2018
'DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironmentJ Rotman, C H Mom, E S Jordanova, et al.
Gynecologic Oncology|October 19, 2001
Cytokine profile of cervical cancer cellsS Hazelbag, G J Fleuren, J J Baelde, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 8, 1990
[Lessons from gynecological-pathological discussions]J B Trimbos, A A Peters, G G Kenter, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 25, 2000
The long learning curve of gynaecological cancer surgery: an argument for centralisationJ B Trimbos, B W Hellebrekers, G G Kenter, et al.
Hematology/Oncology Clinics of North America|March 18, 1999
Immunotherapeutic strategies for cervical squamous carcinomaW J van Driel, G G Kenter, G J Fleuren, et al.
Pageof 9